PHYSICIAN NOTES: Don't Close Off All Off-Label Uses For Oral Chemo Drugs, ASCO Urges

Why This Topic Matters

The article touches multiple areas where coverage policy and carrier guidance can affect reimbursement, compliant claim submission, and access to care. It helps readers identify the general scope of Medicare and CPT/HCPCS-related updates without relying on the full premium text.

Article Sections

1. Oral chemotherapy coverage and ASCO comments to CMS

   Discusses a Medicare coverage demonstration project and professional society comments about how coverage policy may affect oncology drug access. Also notes timing-related FDA review activity for oral cancer drugs.

2. Acupuncture coverage determination

   Summarizes a CMS national coverage position on acupuncture for certain musculoskeletal and pain-related conditions. The section focuses on the broader coverage decision rather than clinical details.

3. Carrier coding guidance and database standardization efforts

   Describes CMS discussions with carrier medical directors about inconsistencies in billing and coding advice. It also mentions plans for a shared database of guidance.

4. ESRD monthly and daily management billing

   Covers carrier guidance on reporting ESRD management services in situations involving beneficiary death or hospitalization. The discussion centers on claim timing, service periods, and related HCPCS reporting.

5. Wound care and bundled procedure billing

   Addresses CPT reporting issues involving selective debridement and related ancillary services. The section explains that a carrier treated certain services as included in the primary procedure.